Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada · Delayed Price · Currency is CAD 1.970
+0.240 (13.87%)
Oct 15, 2026, 9:30 AM EST
TSXV:EBM Market Cap
TSXV:EBM has a market cap or net worth of CAD 135.71 million as of October 15, 2026. It is the 26,578th most valuable company in the world and the 712th biggest in Canada. Its market cap has increased by 342.70% in one year.
Market Cap
135.71M
Enterprise Value
135.77M
Revenue
812.12K
Global Rank
Country Rank
#712 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since September 19, 2014, TSXV:EBM's market cap has increased from 26.94M to 135.71M, an increase of 403.69%. That is a compound annual growth rate of 14.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 135.71M | 143.21% |
| Dec 31, 2025 | 55.80M | 50.00% |
| Dec 31, 2024 | 37.20M | -1.82% |
| Dec 6, 2023 | 37.89M | -45.00% |
| Dec 30, 2022 | 68.89M | -28.57% |
| Dec 30, 2021 | 96.44M | -30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 227.23M |
| ME Therapeutics Holdings | 85.09M |
| Helix BioPharma | 70.27M |
| NurExone Biologic | 57.84M |
| BriaCell Therapeutics | 48.81M |
| Sernova Biotherapeutics | 43.43M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 42.46M |